MYOV - Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q2 2021 Results - Earnings Call Transcript

Myovant Sciences Ltd. (MYOV) Q2 2021 Earnings Conference Call October 26, 2021 08:30 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Dave Marek - Chief Executive Officer Lauren Merendino - Chief Commercial Officer Uneek Mehra - Chief Financial and Business Officer Juan Camilo Arjona - Chief Medical Officer Conference Call Participants Brian Skorney - Baird Phil Nadeau - Cowen Roanna Ruiz - SVB Leerink Gavin Clark-Gartner - Evercore ISI Madhu Kumar - Goldman Sachs Eric Joseph - JPMorgan Presentation Operator Good day everyone and welcome to Myovant Sciences' Second Quarter of Fiscal Year 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, Vice President of Investor Relations at Myovant. Please go ahead. Ryan Crowe Thank you, operator. Good morning and thanks for joining us today to review the financial results of Myovant's second

For further details see:

Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q2 2021 Results - Earnings Call Transcript